category,datetime,headline,id,image,related,source,summary,url
company,1769200260,Alcoa Earnings Send Shares Lower—Buy the Dip or Wait?,138248545,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WFC,Yahoo,"Alcoa beat Q4 earnings estimates, but AA stock fell on guidance; however, fundamentals still support upside in 2026 and makes this a buyable dip",https://finnhub.io/api/news?id=434b72ef79af44f6094f50e09e4fc19fa8549c57ce33facfc2b5c183d9ae75eb
company,1769190629,Wells Fargo announces further layoffs at Jordan Creek campus,138226970,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WFC,Yahoo,"Cuts forecast by CEO Charlie Scharf continue at Wells Fargo, with another round at the company's Jordan Creek facility.",https://finnhub.io/api/news?id=70843822b7d16493ca694c1a9770f00bf777724c299ea6d24f2bc81adba1412d
company,1769185920,Wells Fargo & Co. stock outperforms competitors despite losses on the day,138233556,,WFC,MarketWatch,Wells Fargo & Co. stock outperforms competitors despite losses on the day,https://finnhub.io/api/news?id=4ea591309fc8ced4eb014d92fb0e91890618923cb5c52b092dd67f6c6d909223
company,1769172012,Wells Fargo Remains a Buy on BridgeBio Pharma (BBIO),138224804,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WFC,Yahoo,"BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the Best Russell 2000 Stocks to Buy Right Now. On January 20, Tiago Fauth from Wells Fargo reiterated a Buy rating on the stock and raised the price target to $88 from $84. Earlier on January 12, TD Cowen also reiterated a Buy rating on the stock with […]",https://finnhub.io/api/news?id=d4a4c3a18e1e902d2ad60235154fa451e9c3d92cdb306ec67f21ac99090ab679
company,1769130524,How Wells Fargo’s Bullish Coverage and Specialty Focus At Kinsale Capital Group (KNSL) Has Changed Its Investment Story,138220279,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,WFC,Yahoo,"In recent days, Wells Fargo initiated research coverage on Kinsale Capital Group, highlighting the insurer’s growth outlook supported by new product launches and an expanding specialty market, while other analysts struck a more cautious tone. Alongside this mixed analyst sentiment, Kinsale’s expanding premiums, rapid book value growth, and increased institutional ownership underscore how its niche in hard-to-place risks is shaping its long-term positioning. We’ll now examine how Wells...",https://finnhub.io/api/news?id=7a398dc2d935a1261207162ddea1ee39208554409c38dc5b9447f79e6f7b8caa
